Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Filip Janku currently holds 81,093 shares of Monte Rosa Therapeutics, Inc. (GLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Filip Janku has been a net seller of GLUE stock. They have purchased $0 and sold $132.5K worth of shares.
Filip Janku's most recent insider trade was on Jun 30, 2026, when they sold 5,407 shares at $0.00 per share.
Filip Janku serves as Executive at Monte Rosa Therapeutics, Inc. (GLUE). They have executed 5 insider transactions totaling $132.5K over their tenure at the company.
Filip Janku holds the position of Executive at Monte Rosa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Filip Janku has shown a selling trading pattern, with $0 in total purchases and $132.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Filip Janku was on Jun 30, 2026, when they sold $132.5K worth of GLUE shares. This transaction involved 5,407 shares at $24.50 per share.
Filip Janku currently owns 81,093 shares of Monte Rosa Therapeutics, Inc. (GLUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Filip Janku's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Filip Janku has 5 Form 4 filings on record as an insider at Monte Rosa Therapeutics, Inc..
Set alerts for Filip Janku and 40,000+ other insiders.